Population
Human platelets, n=9 for secretion assays
Design
Preclinical
Authors
Loading...
Cyclo-oxygenase inhibitors may blunt PAF platelet effects; animal data leave open clinical translation.
The major effect of PAF on human platelets appears to be mediated through the cyclo-oxygenase pathway.
Chesney et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: